youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$2.57
arrow_upward
+0.78%(+0.020) 1D
US$2.57
0.00% (0.00)
bedtimeAfter hours
Closed: ኖቬም 6, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$2.55
High
US$2.63
Low
US$2.48
Mkt. cap
394.70 ሚ
Avg. vol.
2.33 ሚ
Volume
1.72 ሚ
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.74
Beta
2.09
Shares outstanding
153.58 ሚ
No. of employees
87
Open
US$2.55
High
US$2.63
Low
US$2.48
Mkt. cap
394.70 ሚ
Avg. vol.
2.33 ሚ
Volume
1.72 ሚ
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.74
Beta
2.09
Shares outstanding
153.58 ሚ
No. of employees
87
News stories
From web sources and news partners
Yahoo Finance
·
ከ21 ሰዓቶች በፊት
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Bloomberg
·
ከ21 ሰዓቶች በፊት
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
AP News
·
ከ1 ቀን በፊት
Carney welcomes Democrats’ push to end Trump’s tariffs on Canada after midterm victory
Investor's Business Daily
·
ከ6 ሰዓቶች በፊት
Dow Jones Futures: Market Damaged, Big Winners Broken; Apple, Amazon, Microsoft Strong
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedኖቬም 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com